Chargement de la fiche…
Chargement de la fiche…

Praticien hospitalier
Photo : Christophe Meneboeuf, CC BY-SA 3.0, Wikimedia Commons
Dans les médias
Vous êtes Dr Anna Molto ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Anna Molto est rhumatologue à Paris 18e (75877). Il consulte à GHU APHP NUP SITE BICHAT C BERNARD, 46 Rue HENRI HUCHARD, 75877 Paris 18e Arrondissement.
Consulter
GHU APHP NUP SITE BICHAT C BERNARD
46 Rue HENRI HUCHARD, 75877 Paris 18e Arrondissement
Dr Anna Molto, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
Diplôme éq d'un pays de l'EEE profession Médecin · DEES Rhumatologie — Capacité / certificat d'études spéciales
Les plus citées
2025Annals of the rheumatic diseases128 citations
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
2025Annals of the rheumatic diseases54 citations
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
2025Rheumatology (Oxford, England)11 citations
Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Anna Molto consulte à GHU APHP NUP SITE BICHAT C BERNARD, 46 Rue HENRI HUCHARD, 75877 Paris 18e Arrondissement. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 01 40 25 80 80 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Paris 18e, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Selection of relevant domains and instruments for the ASAS core set to assess axial spondyloarthritis in clinical practice: a Delphi survey of stakeholders
2026Annals of the rheumatic diseasesPubMed
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project
2026Rheumatology advances in practicePubMed
900 patients evaluated within a median of 1 day from referral in a very early arthritis clinic in France
2025EULAR rheumatology openPubMed
The EULAR Research Center-5 years young and going strong
2025Gynecologie, obstetrique, fertilite & senologiePubMed
[Chronic inflammatory rheumatic diseases and female fertility]
2025Therapeutic advances in musculoskeletal diseasePubMed
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey
2025Joint bone spinePubMed
Translation and cross-cultural adaptation of the Coping with Rheumatic Stressors (CORS) into French language
2025Joint bone spinePubMed
Factors associated with dietary practices and beliefs on food of patients with rheumatic and musculoskeletal diseases: A multicentre cross-sectional study
2026RMD openPubMed
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2026Joint bone spinePubMed
Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France
2026RMD openPubMed
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026Joint bone spinePubMed
Teleconsultation for rheumatoid arthritis: A selective therapeutic tool in routine care
2025Clinical and experimental rheumatologyPubMed
Risk factors associated with venous thromboembolism in rheumatoid arthritis in clinical practice
2025BMC rheumatologyPubMed
Disease activity during pregnancy in patients with rheumatoid arthritis or spondyloarthritis: results from the multicentre prospective GR2 study
2025Rheumatology (Oxford, England)PubMed
Comment on: Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in Systemic Lupus Erythematosus patients: Reply
2025BJOG : an international journal of obstetrics and gynaecologyPubMed
Safety of Fertility Treatments in Women With Systemic Lupus Erythematosus: Data From a Prospective Population-Based Study
2025Rheumatology (Oxford, England)PubMed
Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
2025Rheumatology (Oxford, England)PubMed
Comment on: Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in Systemic Lupus Erythematosus patients: Reply
2025Rheumatology (Oxford, England)PubMed
Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
2025Joint bone spinePubMed
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
2025Annals of the rheumatic diseasesPubMed
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
2026Annals of the rheumatic diseasesPubMed
Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)
2025BMC rheumatologyPubMed
Disease phenotype and management of axial psoriatic arthritis in Japan compared with other regions, particularly other Asian countries: results of the ASAS-PerSpA study
2026 · Article
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2026 · Article
Factors associated with anakinra effectiveness and risk of infection in crystal-related flares
2026 · Article
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026 · Article
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2026 · Article
Preconception, pregnancy and postpartum periods in spondyloarthritis: Unmet needs and challenges from a patients and rheumatologists surveys
2025 · Article
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study
2025 · Article
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
2025 · Article
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: Reply
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.